Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
Child Neurology and Psychiatry Unit, Department of Neurosciences, Policlinico Tor Vergata Foundation Hospital, Rome, Italy.
Am J Med Genet A. 2023 Jul;191(7):1836-1848. doi: 10.1002/ajmg.a.63211. Epub 2023 Apr 17.
Sotos syndrome (SoS) is a congenital overgrowth syndrome with variable degree of intellectual disability caused in the 90% of cases by pathogenetic variants of the Nuclear receptor binding SET Domain protein1 (NSD1) gene. NSD1 gene functions can be abrogated by different genetic alterations (i.e., small intragenic pathogenic variants like deletions/insertions, nonsense/missense pathogenic variants, partial gene deletions and whole deletions or microdeletion of 5q35 chromosomal region). Therefore, correlation of the genotype-phenotype with a possible contribution of more implicated genes to the medical, cognitive and behavioral profile is a topic of great interest. Although a more severe learning disability has been described in individuals with 5q35 microdeletion when compared to individuals with NSD1 intragenic pathogenic variants a fully delineated cognitive and behavioral phenotype has not been described yet. The importance of providing clinical characterization in relation to the genotype comes from the necessity to early identify children more at risk of developing psychopathological disorders. We characterize the cognitive, adaptive and behavioral phenotype of a pediatric sample of 64 individuals affected by SoS, performing a standardized neuropsychological evaluation. Secondly, we compare cognitive-behavioral profiles of SoS individuals carrying and not carrying the 5q35 microdeletion. SoS participants were characterized by a mild cognitive impairment of both Intellectual Quotient and adaptive skills in association to borderline symptoms of attention deficit. Our results suggest that the 5q35 microdeletion is associated with lower scores specifically concerning the cognitive, adaptive functioning and behavioral domains. However, longitudinal studies are necessary to confirm these findings and delineate a developmental trajectory of SoS.
Sotos 综合征(SoS)是一种先天性过度生长综合征,伴有不同程度的智力障碍,在 90%的病例中由核受体结合 SET 域蛋白 1(NSD1)基因突变引起。NSD1 基因的功能可以被不同的遗传改变(即小的基因内致病性变异,如缺失/插入、无义/错义致病性变异、部分基因缺失和整个基因缺失或 5q35 染色体区域的微缺失)所破坏。因此,基因型-表型的相关性以及更多可能涉及的基因对医学、认知和行为特征的可能贡献是一个非常关注的话题。尽管与 NSD1 基因内致病性变异相比,5q35 微缺失的个体存在更严重的学习障碍,但尚未完全描述认知和行为表型。提供与基因型相关的临床特征的重要性源于需要早期识别更有可能发展为精神病理障碍的儿童。我们对 64 名患有 SoS 的儿科患者进行了标准化神经心理学评估,以确定其认知、适应和行为表型。其次,我们比较了携带和不携带 5q35 微缺失的 SoS 个体的认知-行为特征。SoS 患者的智商和适应技能均存在轻度认知障碍,伴有注意力缺陷的边缘症状。我们的结果表明,5q35 微缺失与认知、适应功能和行为领域的分数较低有关。然而,需要进行纵向研究来证实这些发现,并描绘 SoS 的发展轨迹。